FDA Expands Use of Durvalumab to Non–small Cell Lung Cancer
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the immunotherapeutic durvalumab (Imfinzi) to include...
Year: 2018: 2018
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the immunotherapeutic durvalumab (Imfinzi) to include...
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
The field of medical oncology is undergoing a remarkable transformation. Cancers that were once considered death sentences, such as...
Before her husband, Tony, was diagnosed with stomach cancer in 2012, Christy Leonard knew little about caregiving. Leonard, who...
Early detection of cancer is arguably a holy grail in the field of cancer research. Catching the disease at...
The U.S. Food and Drug Administration (FDA) recently added a new therapeutic to the armamentarium for oncologists treating patients...
In honor of International Day of Women and Girls in Science, a United Nations initiative aimed at narrowing a...
The American Association for Cancer Research (AACR) recently appointed Chi Van Dang, MD, PhD, as the new editor-in-chief of...
The American Association for Cancer Research (AACR) is proud to support World Cancer Day, a yearly initiative of the...
The obesity epidemic shows no signs of abating. The World Health Organization estimates that the proportion of the world’s...